Rise In Prevalence Of Diabetes Fueling The Growth Of The Market Due To Shared Autoimmune Links And Dietary Management Needs Driving Market Acceleration in the Celiac Disease Treatment Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Celiac Disease Treatment Market Size By 2025?
The market size for treating celiac disease has seen a significant surge in recent years. The market growth is projected to increase from $0.61 billion in 2024 to $0.66 billion in 2025, averaging an 8.8% compound annual growth rate (CAGR). The historic growth is largely driven by factors such as an increase in the occurrence of celiac disease, improved awareness and diagnostic rates, a rise in demand for treatment options beyond dietary changes, a robust pipeline of innovative therapeutic approaches, encouraging regulatory measures, and heightened interest and investment from pharmaceutical corporations.

How Big Is the Celiac Disease Treatment Market Size Expected to Grow by 2029?
The market for treatment of celiac disease is anticipated to significantly expand in the coming years, projecting a growth to "$0.94 billion by 2029", growing at a compound annual growth rate (CAGR) of 9.3%. The ascend in this projection period can be linked to several factors like surge in celiac disease on a global scale, increase in awareness and diagnosis rates, continuous clinical trials for innovative treatments, rising demand for gluten-free substitutes, beneficial regulatory actions related to orphan diseases, and an increase in healare spending. The foroming period is also likely to see a rise in trends such as the use of new non-dietary therapies, progress in enzyme supplements, personalized medicine approaches, creation of peptide-based immunotherapies, enhanced diagnostic tools, and advancements in clinical trials.

View the full report here:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

Which Key Market Drivers Powering Celiac Disease Treatment Market Expansion and Growth?
The escalating occurrence of diabetes is projected to drive the expansion of the celiac disease treatment market. Diabetes is a long-term ailment where the body fails to control blood sugar or glucose levels suitably. The increasing incidence of diabetes is attributable to similar dietary management necessities since both diabetes and celiac disease necessitate careful supervision of food consumption to manage blood sugar levels and avert complications. Treating celiac disease contributes to diabetes control by endorsing a gluten-free diet. This approach can enhance overall digestive well-being and nutrient absorption, providing better blood sugar management and diminishing complication rates in people handling both conditions. For example, the National Health Service, a government institution based in the UK, reported in June 2024 that approximately 3,615,330 individuals who were registered with a general practitioner (GP) got diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This figure represents an 18% surge from 3,065,825 cases in 2022. Consequently, the escalating prevalence of diabetes is fueling the expansion of the celiac disease treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What Are the Key Trends Driving Celiac Disease Treatment Market Growth?
Leading companies in the celiac disease treatment market are concentrating their efforts on creating oral solutions such as small molecule therapies. These are intended to offer targeted alleviation by impeding immune reactions to gluten, boosting patient compliance, and presenting viable alternatives to strict gluten-free diets. Small molecule therapies are diminutive drugs designed to penetrate cells with ease, and target and mitigate disease-inducing proteins or enzymes. To illustrate, Immunic Inc., an American biotech firm, introduced IMU-856 in February 2025. This small molecule boosts internal levels of glucagon-like peptide-1 (GLP-1), aiding in the enhancement of intestinal barrier function in individuals with celiac disease. Additionally, it boosts nutrient absorption and eases symptoms without constraining immune responses.

What Are the Emerging Segments in the Celiac Disease Treatment Market?
The celiac disease treatment market covered in this report is segmented -

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

Who Are the Global Leaders in the Celiac Disease Treatment Market?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

Which are the Top Profitable Regional Markets for the Celiac Disease Treatment Industry?
North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24186

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.